Oligonucleotide Synthesis Market Is Likely To Surge At An 11.5% CAGR By 2032

The global oligonucleotide synthesis market is poised to grow at a CAGR of 11.3% from 2022 to 2032. During the said forecast period, the industry is expected to close at a valuation of US$ 17 Billion. Oligonucleotides have enormous latent applications in curing an extensive array of medical conditions. They allow the expansion of therapeutics as the crashing genes can be targeted, manipulated, silenced, and/or modulated.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4853?PS

From 2015 to 2021, the market for oligonucleotide synthesis grew at a CAGR of 16.3%, closing at a value of US$ 988 Million. As of 2022, the industry is likely to reach US$ 5.7 Billion. Pharmaceutical companies are concentrating on oligonucleotides as therapeutic agents such as antisense and RNAi therapeutics in the U.S region. These companies are making hefty investments in molecular diagnostics and clinical applications.

"The global oligonucleotide synthesis market exhibits an upward trend. As the nature of health problems becomes complicated with each passing day, demand for more robust and state-of-the-art treatment facilities is increasing. Considering the existing scenario, key market players are concentrating on introducing pathways in synthetic chemistry," comments a Fact.MR analyst.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲

• Global oligonucleotide synthesis market to treble from 2022-2032
• Synthesized oligonucleotide synthesis to be a top-selling category, capturing more than 3/5th revenue and flourishing at a 12.2% CAGR
• By application, oligonucleotide synthesis for the therapeutics to expand at a CAGR of 18.4%
• U.S to emerge as the fastest-growing Oligonucleotide Synthesis market, documenting a 10.2% CAGR
• APAC to be the 2nd most opportunistic market, expected to be valued at US$ 1.7 Billion in 2032

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

The global market for Oligonucleotide Synthesis is characterized by the presence of multiple vendors, aiming to offer extensive consulting and integration services to clients. Additionally, enterprises are seeking out, specialized service providers, offering solutions tailor-made to suit their business objectives. In addition, the vendors are likely to leverage up-gradation and product differentiation to gain an edge over other competitors in the market.

In Jan 2021, Thermo Fisher Scientific Inc., the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplier of services and technologies for the life sciences industry announced that Thermo Fisher has completed the acquisition of Henogen S.A., Novasep's viral vector manufacturing business in Belgium for approximately 725 Mn Euro in cash.

In June 2019, CordenPharma International and GE Healthcare's Dharmacon Business have entered a strategic collaboration to create an end-to-end solution for oligonucleotide-based drug discovery. The collaboration addressed the speed and capacity challenges researchers face when transitioning from research and preclinical stages to drug development and clinical trials.

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐎𝐥𝐢𝐠𝐨𝐧𝐮𝐜𝐥𝐞𝐨𝐭𝐢𝐝𝐞 𝐒𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐒𝐮𝐫𝐯𝐞𝐲

Oligonucleotide Synthesis by Product :

Oligonucleotide Synthesis Reagents & Consumables
Oligonucleotide Synthesis Equipment
Synthesized Oligonucleotides:
DNA Oligonucleotides
RNA Oligonucleotides
Other Oligonucleotide Synthesis Products

Oligonucleotide Synthesis by Application :

Oligonucleotide Synthesis for Research
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing
Others
Oligonucleotide Synthesis for Therapeutics
Antisense Oligonucleotides
Nucleic Acid Aptamers
Oligonucleotide Synthesis for Diagnostics

Oligonucleotide Synthesis by End User :

Oligonucleotide Synthesis Products for Biotechnology & Pharmaceutical Companies
Oligonucleotide Synthesis Products for Research Institutes
Oligonucleotide Synthesis Products for Diagnostic Laboratories

Oligonucleotide Synthesis by Region :

North America Oligonucleotide Synthesis Market
Latin America Oligonucleotide Synthesis Market
Europe Oligonucleotide Synthesis Market
Asia Pacific Oligonucleotide Synthesis Market
Middle East & Africa Oligonucleotide Synthesis Market

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4853?PS

𝐌𝐨𝐫𝐞 𝐕𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

Fact.MR, in its new offering, presents an unbiased analysis of the global Oligonucleotide Synthesis market, presenting a historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of product (reagents & consumables, equipment, synthesized oligonucleotides, DNA oligonucleotides, RNA oligonucleotides and others), application (research and therapeutics) and end user (biotechnology & pharmaceutical companies, research institutes and diagnostic laboratories) across five major regions (North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa).

Contact:

Us Sales Office :
11140 Rockville Pike
Suite 400
Rockville, Md 20852
United States
Tel: +1 (628) 251-1583

About Fact. MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical, and materials, to even the most niche categories.

This release was published on openPR.